Sale of Berlinger & Co. AG to Carrier Global Corporation
The owner family has agreed to sell the monitoring solutions business of Berlinger & Co. AG to Sensitech Inc. (Carrier Global Incorporation). The transaction is expected to be closed in the third quarter of 2024.
BÜHLMANN Laboratories AG sold to KLAR Partners
Dr. Roland P. Bühlmann and his wife Marie-Thérèse Bühlmann sold all shares in BÜHLMANN Laboratories AG to KLAR Partners Limited on 5 June 2024.
Provider liability: VISCHER to achieve a landmark acquittal
In a landmark judgment (defamation case) of earlier this year, the District Court of Visp/Valais acquitted the managing director of a leading Swiss hosting provider and domain registrar.
Sale of gammaRenax to ISS
The shareholders of gammaRenax AG have sold their company to ISS Facility Services AG. gammaRenax is an efficient quality provider of integrated facility services with 1'800 employees at 16 locations in all regions of Switzerland.
BID Equity acquires Realview
BID Equity acquires Realview AG, which develops and distributes software for the Swiss construction industry.
Memo Therapeutics AG Increases Series C Financing to CHF 45m
Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.
Narrowin and EnBW enter partnership
The German energy supplier EnBW enters into a partnership with narrowin GmbH, a Swiss cybersecurity start-up. As part of the cooperation, EnBW is also making a financial investment in narrowin via EnPulse Ventures GmbH.
Oculis completes $59m Share Placemement and Listing on Nasdaq Iceland
Oculis Holding AG (Nasdaq: OCS) completed a financing of approximately $59 million, consisting of the issuance of 5,000,000 of its ordinary shares at a purchase price of $11.75 per share.
Odne completes financing round
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch for their minimal invasive Root Preservation Technology (RPT).
Artiria Medical SA raises USD 6m in a Series A2 Financing Round
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation neuro-interventional products for stroke and aneurysms, closed a USD 6m series A2 financing round.